SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-050064
Filing Date
2024-04-29
Accepted
2024-04-29 17:25:26
Documents
3
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A 2024_proxy.htm DEF 14A 666010
2 GRAPHIC img73917039_0.jpg GRAPHIC 125396
3 GRAPHIC img73917039_1.jpg GRAPHIC 118331
  Complete submission text file 0000950170-24-050064.txt   1003005
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 212-994-8250
MiNK Therapeutics, Inc. (Filer) CIK: 0001840229 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40908 | Film No.: 24892943
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)